[
  {
    "ts": null,
    "headline": "Biogen Inc. stock underperforms Friday when compared to competitors",
    "summary": "Biogen Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=7aa2a535e57e9806b86244456a5a71890b9c86bf5bcda17d55c71d74ce730e23",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734714660,
      "headline": "Biogen Inc. stock underperforms Friday when compared to competitors",
      "id": 132158702,
      "image": "",
      "related": "BIIB",
      "source": "MarketWatch",
      "summary": "Biogen Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=7aa2a535e57e9806b86244456a5a71890b9c86bf5bcda17d55c71d74ce730e23"
    }
  },
  {
    "ts": null,
    "headline": "BMO cuts rating on Merck and Biogen, on lack of near term catalyst",
    "summary": "Investing.com -- BMO Capital Markets downgraded Merck &Company Inc (NYSE:MRK) to \"market perform\" from \"outperform,\" citing concerns over its Gardasil franchise in China and uncertainty around filling the revenue gap as Keytruda faces loss of exclusivity and biosimilar competition.",
    "url": "https://finnhub.io/api/news?id=d059b0bd5c61e2c8c0d94c46c4569ffcaf65d5bf70d191364489f84223618cf3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734705894,
      "headline": "BMO cuts rating on Merck and Biogen, on lack of near term catalyst",
      "id": 132077718,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Investing.com -- BMO Capital Markets downgraded Merck &Company Inc (NYSE:MRK) to \"market perform\" from \"outperform,\" citing concerns over its Gardasil franchise in China and uncertainty around filling the revenue gap as Keytruda faces loss of exclusivity and biosimilar competition.",
      "url": "https://finnhub.io/api/news?id=d059b0bd5c61e2c8c0d94c46c4569ffcaf65d5bf70d191364489f84223618cf3"
    }
  },
  {
    "ts": null,
    "headline": "Impax Ellevate Global Women's Leadership Fund Q3 2024 Commentary",
    "summary": "The Impax Global Womenâs Leadership Fund outperformed its benchmark in Q3 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=320e5055829731ea3de7d0e76a2ecae2e07406bb21bcd74c624f2224ff955e2c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734674700,
      "headline": "Impax Ellevate Global Women's Leadership Fund Q3 2024 Commentary",
      "id": 132070668,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1194611027/image_1194611027.jpg?io=getty-c-w1536",
      "related": "BIIB",
      "source": "SeekingAlpha",
      "summary": "The Impax Global Womenâs Leadership Fund outperformed its benchmark in Q3 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=320e5055829731ea3de7d0e76a2ecae2e07406bb21bcd74c624f2224ff955e2c"
    }
  }
]